Birchview Capital’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Hold |
20,000
| – | – | 0.15% | 63 |
|
|
2025
Q1 | $151K | Hold |
20,000
| – | – | 0.13% | 57 |
|
|
2024
Q4 | $244K | Hold |
20,000
| – | – | 0.2% | 53 |
|
|
2024
Q3 | $335K | Hold |
20,000
| – | – | 0.29% | 41 |
|
|
2024
Q2 | $349K | Sell |
20,000
-5,114
| -20% | -$89.2K | 0.32% | 40 |
|
|
2024
Q1 | $428K | Hold |
25,114
| – | – | 0.35% | 38 |
|
|
2023
Q4 | $256K | Hold |
25,114
| – | – | 0.2% | 45 |
|
|
2023
Q3 | $227K | Hold |
25,114
| – | – | 0.19% | 44 |
|
|
2023
Q2 | $270K | Hold |
25,114
| – | – | 0.2% | 48 |
|
|
2023
Q1 | $257K | Hold |
25,114
| – | – | 0.2% | 46 |
|
|
2022
Q4 | $265K | Hold |
25,114
| – | – | 0.19% | 46 |
|
|
2022
Q3 | $322K | Sell |
25,114
-20,000
| -44% | -$256K | 0.23% | 46 |
|
|
2022
Q2 | $578K | Hold |
45,114
| – | – | 0.42% | 35 |
|
|
2022
Q1 | $472K | Hold |
45,114
| – | – | 0.34% | 42 |
|
|
2021
Q4 | $696K | Hold |
45,114
| – | – | 0.45% | 36 |
|
|
2021
Q3 | $1.02M | Hold |
45,114
| – | – | 0.69% | 28 |
|
|
2021
Q2 | $1.16M | Sell |
45,114
-15,000
| -25% | -$386K | 0.7% | 25 |
|
|
2021
Q1 | $2.51M | Buy |
+60,114
| New | +$2.51M | 1.49% | 12 |
|